関連する実験動画
Updated: Aug 18, 2026

06:51
Techniques to Induce and Quantify Cellular Senescence
Published on: May 1, 2017
c-fos転写の抑制と老化しているヒト線維芽細胞の変異遺伝子プログラム
1Department of Biochemistry, Boston University Medical School, MA 02118.
まとめ
細胞衰老は,不可逆的な細胞サイクル停止の状態であり,重要な遺伝子発現の変化を含みます. 重要な発見は,c-fos遺伝子発現の抑制が,老朽化した線維芽細胞の増殖不能に寄与することを示しています.
科学分野:
- 細胞生物学 細胞生物学
- 分子遺伝学 分子遺伝学
背景:
- 培養中の正常な細胞は老化期に入り,細胞分裂の有限な数の後に増殖を停止します.
- 細胞老化は,遺伝子発現パターンの不可逆的な変化を含む複雑なプロセスです.
研究 の 目的:
- 人間の胎児の肺線維芽細胞の細胞老化中に発生する特定の遺伝子発現の変化を調査する.
- 衰老細胞の増殖停止における特定の遺伝子抑制,特にc-fosの役割を決定する.
主な方法:
- 衰老した線維芽細胞におけるヒストン,腫瘍遺伝子 (c-H-ras,c-myc),およびc-fosプロト腫瘍遺伝子を含む様々な遺伝子に対するメッセンジャーRNA (mRNA) レベルの分析.
- 血清刺激に対するオルニチンデカルボキシラーゼの活性に対する評価.
- 遺伝子誘導に影響を与える転写ブロックの調査.
主要な成果:
- 衰老した線維芽細胞は,非細胞周期調節mRNAの抑制と異常なポリアデニルヒストンのmRNAの発現を示した.
- 血清が誘発したc-H-ras,c-myc,オルニチンデカルボキシラーゼmRNAは,オルニチンデカルボキシラーゼの活性が不足していました.
- 血清は,複製依存ヒストンおよびc-fosプロトオンコゲンのためのmRNAを誘導できず,c-fos.のために特定された特定の転写ブロックが特定されました.
結論:
- 転写ブロックによるc-fosの選択的抑制は,老化性線維芽細胞の増殖能力の低下に寄与する重要な要因である.
- 観察された複数の遺伝子発現の変化は,端末分化の一形態としての細胞老化のモデルを支持する.
さらに関連する動画
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
10:08Senescence Detection Using Reflected Light in Adipose Stromal Vascular Fraction
Published on: June 5, 2026
関連する概念動画
Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...